mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
Sunitinib |
FIMM |
pan-cancer |
AAC |
0.12 |
0.5 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
Nilotinib |
FIMM |
pan-cancer |
AAC |
0.12 |
0.5 |
mRNA |
AUY922 |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.5 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.5 |